{"id":347685,"date":"2025-08-25T12:50:54","date_gmt":"2025-08-25T12:50:54","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-ovid-therapeutics\/"},"modified":"2025-08-25T12:50:54","modified_gmt":"2025-08-25T12:50:54","slug":"how-to-buy-ovid-therapeutics","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ovid-therapeutics\/","title":{"rendered":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Ovid Therapeutics Inc. (OVID) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Ovid Therapeutics Inc. (OVID)"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334117,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-347685","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Ovid Therapeutics Inc. (OVID) - \u0110\u1ea7u T\u01b0 V\u00e0o C\u1ed5 Phi\u1ebfu Ovid Therapeutics Inc. (OVID)","h1_source":{"label":"H1","type":"text","formatted_value":"C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Ovid Therapeutics Inc. (OVID) - \u0110\u1ea7u T\u01b0 V\u00e0o C\u1ed5 Phi\u1ebfu Ovid Therapeutics Inc. (OVID)"},"description":"T\u00ecm hi\u1ec3u c\u00e1ch mua c\u1ed5 phi\u1ebfu Ovid Therapeutics Inc. (OVID) v\u1edbi ph\u00e2n t\u00edch \u0111\u1ea7u t\u01b0 \u0111\u1ea7y \u0111\u1ee7 c\u1ee7a ch\u00fang t\u00f4i bao g\u1ed3m d\u1ef1 b\u00e1o gi\u00e1, r\u1ee7i ro v\u00e0 h\u01b0\u1edbng d\u1eabn mua t\u1eebng b\u01b0\u1edbc.","description_source":{"label":"Description","type":"textarea","formatted_value":"T\u00ecm hi\u1ec3u c\u00e1ch mua c\u1ed5 phi\u1ebfu Ovid Therapeutics Inc. (OVID) v\u1edbi ph\u00e2n t\u00edch \u0111\u1ea7u t\u01b0 \u0111\u1ea7y \u0111\u1ee7 c\u1ee7a ch\u00fang t\u00f4i bao g\u1ed3m d\u1ef1 b\u00e1o gi\u00e1, r\u1ee7i ro v\u00e0 h\u01b0\u1edbng d\u1eabn mua t\u1eebng b\u01b0\u1edbc."},"intro":"B\u1ea1n \u0111ang ngh\u0129 \u0111\u1ebfn vi\u1ec7c \u0111\u1ea7u t\u01b0 v\u00e0o l\u0129nh v\u1ef1c y h\u1ecdc th\u1ea7n kinh ti\u00ean ti\u1ebfn? Ovid Therapeutics Inc. (OVID) \u0111\u1ea1i di\u1ec7n cho m\u1ed9t trong nh\u1eefng c\u01a1 h\u1ed9i th\u00fa v\u1ecb nh\u1ea5t \u2014 v\u00e0 bi\u1ebfn \u0111\u1ed9ng nh\u1ea5t \u2014 trong ng\u00e0nh c\u00f4ng ngh\u1ec7 sinh h\u1ecdc. C\u00f4ng ty n\u00e0y \u0111ang ti\u00ean phong trong c\u00e1c ph\u01b0\u01a1ng ph\u00e1p \u0111i\u1ec1u tr\u1ecb c\u00e1c r\u1ed1i lo\u1ea1n n\u00e3o \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn h\u00e0ng tri\u1ec7u ng\u01b0\u1eddi tr\u00ean to\u00e0n th\u1ebf gi\u1edbi, bi\u1ebfn n\u00f3 th\u00e0nh m\u1ed9t y\u1ebfu t\u1ed1 thay \u0111\u1ed5i cu\u1ed9c ch\u01a1i ti\u1ec1m n\u0103ng cho c\u1ea3 b\u1ec7nh nh\u00e2n v\u00e0 nh\u00e0 \u0111\u1ea7u t\u01b0. H\u00e3y c\u00f9ng kh\u00e1m ph\u00e1 \u0111i\u1ec1u g\u00ec l\u00e0m cho c\u1ed5 phi\u1ebfu n\u00e0y tr\u1edf n\u00ean h\u1ea5p d\u1eabn v\u00e0 c\u00e1ch b\u1ea1n c\u00f3 th\u1ec3 th\u00eam n\u00f3 m\u1ed9t c\u00e1ch chi\u1ebfn l\u01b0\u1ee3c v\u00e0o danh m\u1ee5c \u0111\u1ea7u t\u01b0 c\u1ee7a m\u00ecnh.","intro_source":{"label":"Intro","type":"text","formatted_value":"B\u1ea1n \u0111ang ngh\u0129 \u0111\u1ebfn vi\u1ec7c \u0111\u1ea7u t\u01b0 v\u00e0o l\u0129nh v\u1ef1c y h\u1ecdc th\u1ea7n kinh ti\u00ean ti\u1ebfn? Ovid Therapeutics Inc. (OVID) \u0111\u1ea1i di\u1ec7n cho m\u1ed9t trong nh\u1eefng c\u01a1 h\u1ed9i th\u00fa v\u1ecb nh\u1ea5t \u2014 v\u00e0 bi\u1ebfn \u0111\u1ed9ng nh\u1ea5t \u2014 trong ng\u00e0nh c\u00f4ng ngh\u1ec7 sinh h\u1ecdc. C\u00f4ng ty n\u00e0y \u0111ang ti\u00ean phong trong c\u00e1c ph\u01b0\u01a1ng ph\u00e1p \u0111i\u1ec1u tr\u1ecb c\u00e1c r\u1ed1i lo\u1ea1n n\u00e3o \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn h\u00e0ng tri\u1ec7u ng\u01b0\u1eddi tr\u00ean to\u00e0n th\u1ebf gi\u1edbi, bi\u1ebfn n\u00f3 th\u00e0nh m\u1ed9t y\u1ebfu t\u1ed1 thay \u0111\u1ed5i cu\u1ed9c ch\u01a1i ti\u1ec1m n\u0103ng cho c\u1ea3 b\u1ec7nh nh\u00e2n v\u00e0 nh\u00e0 \u0111\u1ea7u t\u01b0. H\u00e3y c\u00f9ng kh\u00e1m ph\u00e1 \u0111i\u1ec1u g\u00ec l\u00e0m cho c\u1ed5 phi\u1ebfu n\u00e0y tr\u1edf n\u00ean h\u1ea5p d\u1eabn v\u00e0 c\u00e1ch b\u1ea1n c\u00f3 th\u1ec3 th\u00eam n\u00f3 m\u1ed9t c\u00e1ch chi\u1ebfn l\u01b0\u1ee3c v\u00e0o danh m\u1ee5c \u0111\u1ea7u t\u01b0 c\u1ee7a m\u00ecnh."},"body_html":"<h2>\ud83d\udcc8 C\u1ed5 Phi\u1ebfu Ovid Therapeutics: Gi\u00e1 Hi\u1ec7n T\u1ea1i v\u00e0 C\u00e1c Ng\u00e0y Quan Tr\u1ecdng<\/h2> <p>T\u00ednh \u0111\u1ebfn ng\u00e0y 25 th\u00e1ng 8 n\u0103m 2025, Ovid Therapeutics Inc. (OVID) giao d\u1ecbch \u1edf m\u1ee9c <strong>1,03 USD<\/strong> m\u1ed7i c\u1ed5 phi\u1ebfu. Nh\u01b0ng h\u00e3y \u0111\u00e1nh d\u1ea5u l\u1ecbch c\u1ee7a b\u1ea1n: <strong>Th\u00e1ng 11 n\u0103m 2025<\/strong> c\u00f3 th\u1ec3 l\u00e0 th\u1eddi \u0111i\u1ec3m b\u00f9ng n\u1ed5 cho c\u1ed5 phi\u1ebfu n\u00e0y. \u0110\u00f3 l\u00e0 khi c\u00f4ng ty d\u1ef1 ki\u1ebfn s\u1ebd c\u00f4ng b\u1ed1 b\u00e1o c\u00e1o thu nh\u1eadp ti\u1ebfp theo, v\u00e0 d\u1ef1a tr\u00ean l\u1ecbch s\u1eed g\u1ea7n \u0111\u00e2y, nh\u1eefng s\u1ef1 ki\u1ec7n n\u00e0y \u0111\u00e3 khi\u1ebfn OVID bi\u1ebfn \u0111\u1ed9ng m\u1ea1nh m\u1ebd.<\/p> <h3>C\u00e1ch B\u00e1o C\u00e1o Thu Nh\u1eadp \u1ea2nh H\u01b0\u1edfng \u0110\u1ebfn C\u1ed5 Phi\u1ebfu OVID<\/h3> <p>B\u00e1o c\u00e1o thu nh\u1eadp g\u1ea7n nh\u1ea5t v\u00e0o ng\u00e0y 13 th\u00e1ng 8 n\u0103m 2025 \u0111\u00e3 t\u1ea1o ra l\u00e0n s\u00f3ng ch\u1ea5n \u0111\u1ed9ng tr\u00ean th\u1ecb tr\u01b0\u1eddng. C\u00f4ng ty b\u00e1o c\u00e1o doanh thu 6,27 tri\u1ec7u USD \u2014 t\u0103ng m\u1ea1nh <strong>3.611%<\/strong> so v\u1edbi c\u00f9ng k\u1ef3 n\u0103m tr\u01b0\u1edbc! M\u1eb7c d\u00f9 ghi nh\u1eadn l\u1ed7 r\u00f2ng 4,68 tri\u1ec7u USD do chi ti\u00eau R&D t\u0103ng cao, c\u1ed5 phi\u1ebfu \u0111\u00e3 t\u0103ng v\u1ecdt <strong>52,61%<\/strong> trong phi\u00ean giao d\u1ecbch ti\u1ebfp theo (<a href=\"https:\/\/www.ainvest.com\/news\/ovid-therapeutics-reports-q2-2025-financials-7mln-royalty-deal-q3-2025-results-expected-2508\/\">B\u00e1o c\u00e1o AInvest<\/a>).<\/p> <p>M\u1eabu h\u00ecnh n\u00e0y kh\u00f4ng ph\u1ea3i l\u00e0 m\u1edbi. C\u00e1c c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc nh\u01b0 OVID s\u1ed1ng v\u00e0 ch\u1ebft d\u1ef1a v\u00e0o k\u1ebft qu\u1ea3 th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng v\u00e0 c\u00e1c b\u1ea5t ng\u1edd v\u1ec1 thu nh\u1eadp. B\u00e1o c\u00e1o th\u00e1ng 11 s\u1eafp t\u1edbi c\u00f3 th\u1ec3 c\u0169ng s\u1ebd r\u1ea5t k\u1ecbch t\u00ednh, \u0111\u1eb7c bi\u1ec7t v\u1edbi c\u00e1c d\u1eef li\u1ec7u quan tr\u1ecdng d\u1ef1 ki\u1ebfn cho ph\u01b0\u01a1ng ph\u00e1p \u0111i\u1ec1u tr\u1ecb OV329 c\u1ee7a h\u1ecd.<\/p> [cta_green text=\"B\u1eaft \u0111\u1ea7u giao d\u1ecbch\"]<h2>\ud83d\udd0d H\u00e0nh Tr\u00ecnh Gi\u00e1 6 Th\u00e1ng: C\u1ea3m Gi\u00e1c T\u00e0u L\u01b0\u1ee3n Si\u00eau T\u1ed1c<\/h2> <p>Di\u1ec5n bi\u1ebfn gi\u00e1 c\u1ee7a OVID trong s\u00e1u th\u00e1ng qua th\u1eadt s\u1ef1 ngo\u1ea1n m\u1ee5c:<\/p> <ul> <li><strong>Th\u00e1ng 2-3 n\u0103m 2025<\/strong>: C\u1ed5 phi\u1ebfu giao d\u1ecbch trong kho\u1ea3ng 0,60-0,70 USD, th\u1ec3 hi\u1ec7n s\u1ef1 bi\u1ebfn \u0111\u1ed9ng \u0111i\u1ec3n h\u00ecnh c\u1ee7a c\u00f4ng ngh\u1ec7 sinh h\u1ecdc<\/li> <li><strong>Th\u00e1ng 4-6 n\u0103m 2025<\/strong>: Gi\u1ea3m d\u1ea7n xu\u1ed1ng kho\u1ea3ng 0,24-0,40 USD \u2014 giai \u0111o\u1ea1n \"ch\u1edd \u0111\u1ee3i\" tr\u01b0\u1edbc c\u00e1c ch\u1ea5t x\u00fac t\u00e1c l\u1edbn<\/li> <li><strong>Th\u00e1ng 7 n\u0103m 2025<\/strong>: Di chuy\u1ec3n b\u00f9ng n\u1ed5 v\u1edbi bi\u1ebfn \u0111\u1ed9ng trung b\u00ecnh h\u00e0ng ng\u00e0y <strong>11,15%<\/strong>, bao g\u1ed3m dao \u0111\u1ed9ng trong ng\u00e0y 14,79%<\/li> <li><strong>Th\u00e1ng 8 n\u0103m 2025<\/strong>: B\u1ee9t ph\u00e1 l\u1edbn \u2014 t\u0103ng <strong>163,59%<\/strong> trong m\u1ed9t th\u00e1ng sau b\u00e1o c\u00e1o thu nh\u1eadp t\u00edch c\u1ef1c v\u00e0 c\u1eadp nh\u1eadt l\u00e2m s\u00e0ng<\/li> <\/ul> <p>T\u1ea1i sao l\u1ea1i c\u00f3 nh\u1eefng bi\u1ebfn \u0111\u1ed9ng m\u1ea1nh nh\u01b0 v\u1eady? OVID \u0111\u1ea1i di\u1ec7n cho b\u1ea3n ch\u1ea5t thu\u1ea7n t\u00fay c\u1ee7a \u0111\u1ea7u t\u01b0 c\u00f4ng ngh\u1ec7 sinh h\u1ecdc: r\u1ee7i ro cao, ph\u1ea7n th\u01b0\u1edfng cao. C\u1ed5 phi\u1ebfu \u0111\u00e3 ch\u1ea1m \u0111\u00e1y 52 tu\u1ea7n \u1edf m\u1ee9c <strong>0,24 USD<\/strong> v\u00e0 \u0111\u1ec9nh 52 tu\u1ea7n \u1edf m\u1ee9c <strong>1,47 USD<\/strong> trong kho\u1ea3ng th\u1eddi gian n\u00e0y, cho th\u1ea5y ti\u1ec1m n\u0103ng bi\u00ean \u0111\u1ed9 c\u1ef1c l\u1edbn (<a href=\"https:\/\/stockinvest.us\/stock\/OVID\">D\u1eef li\u1ec7u StockInvest<\/a>).<\/p> <h2>\ud83d\udd2e D\u1ef1 B\u00e1o Gi\u00e1: Tri\u1ec3n V\u1ecdng 2025-2030<\/h2> <ul> <li><strong>Cu\u1ed1i n\u0103m 2025<\/strong>: Kho\u1ea3ng 3,10-7,14 USD (ti\u1ec1m n\u0103ng t\u0103ng 200-578%) \u2192 <strong>MUA M\u1ea0NH<\/strong><br> C\u00e1c nh\u00e0 ph\u00e2n t\u00edch r\u1ea5t l\u1ea1c quan, v\u1edbi m\u1ee5c ti\u00eau gi\u00e1 trung b\u00ecnh l\u00e0 3,10 USD v\u00e0 c\u00e1c m\u00f4 h\u00ecnh k\u1ef9 thu\u1eadt d\u1ef1 \u0111o\u00e1n l\u00ean \u0111\u1ebfn 7,14 USD (<a href=\"https:\/\/stockscan.io\/stocks\/OVID\/forecast\">D\u1ef1 b\u00e1o StockScan<\/a>). Ch\u1ea5t x\u00fac t\u00e1c ch\u00ednh? D\u1eef li\u1ec7u giai \u0111o\u1ea1n 1 c\u1ee7a OV329 d\u1ef1 ki\u1ebfn trong qu\u00fd 3 n\u0103m 2025.<\/li> <li><strong>D\u1ef1 b\u00e1o 2026<\/strong>: Kho\u1ea3ng 0,495-3,50 USD<br> S\u1ef1 ph\u00e2n k\u1ef3 \u1edf \u0111\u00e2y ph\u1ea3n \u00e1nh t\u00ednh nh\u1ecb ph\u00e2n c\u1ee7a c\u00f4ng ngh\u1ec7 sinh h\u1ecdc \u2014 ho\u1eb7c th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng th\u00e0nh c\u00f4ng (kho\u1ea3ng cao h\u01a1n) ho\u1eb7c g\u1eb7p kh\u00f3 kh\u0103n (kho\u1ea3ng th\u1ea5p h\u01a1n).<\/li> <li><strong>D\u1ef1 b\u00e1o 2028<\/strong>: 0,225-1,00 USD<br> C\u00e1c m\u00f4 h\u00ecnh d\u00e0i h\u1ea1n cho th\u1ea5y \u01b0\u1edbc t\u00ednh th\u1eadn tr\u1ecdng, nh\u01b0ng vi\u1ec7c ph\u00ea duy\u1ec7t thu\u1ed1c th\u00e0nh c\u00f4ng c\u00f3 th\u1ec3 thay \u0111\u1ed5i \u0111\u00e1ng k\u1ec3 tri\u1ec3n v\u1ecdng n\u00e0y.<\/li> <li><strong>Tri\u1ec3n v\u1ecdng 2030<\/strong>: R\u1ea5t mang t\u00ednh \u0111\u1ea7u c\u01a1<br> \u0110\u1ebfn n\u0103m 2030, n\u1ebfu OVID c\u00f3 th\u1ec3 \u0111\u01b0a ra \u00edt nh\u1ea5t m\u1ed9t lo\u1ea1i thu\u1ed1c \u0111\u01b0\u1ee3c ph\u00ea duy\u1ec7t, c\u1ed5 phi\u1ebfu c\u00f3 th\u1ec3 t\u0103ng l\u00ean \u0111\u00e1ng k\u1ec3. Tuy nhi\u00ean, \u0111\u00e2y v\u1eabn l\u00e0 ph\u1ea7n r\u1ee7i ro nh\u1ea5t trong d\u1ef1 b\u00e1o.<\/li> <\/ul> <h2>\u26a0\ufe0f R\u1ee7i Ro Ch\u00ednh v\u00e0 T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c<\/h2> <h3>R\u1ee7i ro c\u1ea7n c\u00e2n nh\u1eafc:<\/h3> <ul> <li><strong>Ti\u00eau ti\u1ec1n m\u1eb7t<\/strong>: D\u01b0\u1edbi m\u1ed9t n\u0103m d\u00f2ng ti\u1ec1n ho\u1ea1t \u0111\u1ed9ng m\u1eb7c d\u00f9 c\u00f3 38,3 tri\u1ec7u USD ti\u1ec1n m\u1eb7t<\/li> <li><strong>Th\u1ea5t b\u1ea1i th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng<\/strong>: D\u1eef li\u1ec7u giai \u0111o\u1ea1n 1 c\u1ee7a OV329 c\u00f3 th\u1ec3 l\u00e0m nh\u00e0 \u0111\u1ea7u t\u01b0 th\u1ea5t v\u1ecdng<\/li> <li><strong>Bi\u1ebfn \u0111\u1ed9ng c\u1ef1c \u0111oan<\/strong>: Dao \u0111\u1ed9ng trung b\u00ecnh h\u00e0ng ng\u00e0y 11,15% c\u00f3 th\u1ec3 th\u1eed th\u00e1ch s\u1ef1 ki\u00ean nh\u1eabn c\u1ee7a b\u1ea5t k\u1ef3 nh\u00e0 \u0111\u1ea7u t\u01b0 n\u00e0o<\/li> <li><strong>R\u1ee7i ro pha lo\u00e3ng<\/strong>: Kh\u1ea3 n\u0103ng cao s\u1ebd c\u00f3 th\u00eam c\u00e1c \u0111\u1ee3t ph\u00e1t h\u00e0nh c\u1ed5 phi\u1ebfu \u0111\u1ec3 t\u00e0i tr\u1ee3 ho\u1ea1t \u0111\u1ed9ng<\/li> <\/ul> <h3>T\u00edn hi\u1ec7u t\u00edch c\u1ef1c cho n\u0103m 2025:<\/h3> <ul> <li><strong>Doanh thu b\u00f9ng n\u1ed5<\/strong>: T\u0103ng tr\u01b0\u1edfng 3.611% so v\u1edbi c\u00f9ng k\u1ef3 n\u0103m tr\u01b0\u1edbc cho th\u1ea5y ti\u1ec1m n\u0103ng m\u00f4 h\u00ecnh kinh doanh<\/li> <li><strong>Ti\u1ebfn tri\u1ec3n trong danh m\u1ee5c s\u1ea3n ph\u1ea9m<\/strong>: D\u1eef li\u1ec7u giai \u0111o\u1ea1n 1 c\u1ee7a OV329 d\u1ef1 ki\u1ebfn qu\u00fd 3 n\u0103m 2025 \u2014 ch\u1ea5t x\u00fac t\u00e1c l\u1edbn<\/li> <li><strong>Th\u1ecfa thu\u1eadn chi\u1ebfn l\u01b0\u1ee3c<\/strong>: H\u1ee3p \u0111\u1ed3ng b\u1ea3n quy\u1ec1n 7 tri\u1ec7u USD v\u1edbi Immedica k\u00e9o d\u00e0i d\u00f2ng ti\u1ec1n<\/li> <li><strong>Xu h\u01b0\u1edbng ng\u00e0nh<\/strong>: \u0110i\u1ec1u tr\u1ecb r\u1ed1i lo\u1ea1n h\u1ec7 th\u1ea7n kinh trung \u01b0\u01a1ng \u0111\u1ea1i di\u1ec7n cho c\u01a1 h\u1ed9i th\u1ecb tr\u01b0\u1eddng tr\u00ean 150 t\u1ef7 USD<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Nh\u00e0 Giao D\u1ecbch M\u1edbi N\u00ean L\u00e0m G\u00ec H\u00f4m Nay?<\/h2> <ol> <li><strong>B\u1eaft \u0111\u1ea7u nh\u1ecf<\/strong>: Ph\u00e2n b\u1ed5 kh\u00f4ng qu\u00e1 2-5% danh m\u1ee5c \u0111\u1ea7u t\u01b0 v\u00e0o c\u00f4ng ngh\u1ec7 sinh h\u1ecdc r\u1ee7i ro cao nh\u01b0 OVID<\/li> <li><strong>Trung b\u00ecnh gi\u00e1<\/strong>: Mua t\u1eebng ph\u1ea7n nh\u1ecf thay v\u00ec mua m\u1ed9t l\u1ea7n l\u1edbn<\/li> <li><strong>\u0110\u1eb7t l\u1ec7nh d\u1eebng l\u1ed7<\/strong>: B\u1ea3o v\u1ec7 b\u1ea3n th\u00e2n kh\u1ecfi bi\u1ebfn \u0111\u1ed9ng gi\u1ea3m m\u1ea1nh<\/li> <li><strong>Theo d\u00f5i c\u00e1c ch\u1ea5t x\u00fac t\u00e1c<\/strong>: \u0110\u00e1nh d\u1ea5u ng\u00e0y b\u00e1o c\u00e1o thu nh\u1eadp th\u00e1ng 11 n\u0103m 2025 v\u00e0 d\u1eef li\u1ec7u l\u00e2m s\u00e0ng qu\u00fd 3<\/li> <\/ol> <p>Ch\u00e2m bi\u1ebfm: \"Giao d\u1ecbch OVID gi\u1ed1ng nh\u01b0 h\u1eb9n h\u00f2 v\u1edbi m\u1ed9t nh\u00e0 th\u1ea7n kinh h\u1ecdc \u2014 ti\u1ec1m n\u0103ng tuy\u1ec7t v\u1eddi, c\u1ea3m x\u00fac kh\u00f3 \u0111o\u00e1n v\u00e0 c\u1ea7n thu\u1ed1c d\u1ea1 d\u00e0y m\u1ea1nh!\"<\/p> <h2>\u2705 C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Ovid Therapeutics Inc. (OVID) - T\u1eebng B\u01b0\u1edbc<\/h2> <table> <thead> <tr><th>B\u01b0\u1edbc<\/th><th>H\u00e0nh \u0110\u1ed9ng<\/th><th>T\u1ea1i Sao Quan Tr\u1ecdng<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Ch\u1ecdn n\u1ec1n t\u1ea3ng giao d\u1ecbch<\/td><td>\u0110\u1ea3m b\u1ea3o n\u1ec1n t\u1ea3ng c\u00f3 truy c\u1eadp NASDAQ v\u00e0 c\u00f3 c\u1ed5 phi\u1ebfu OVID<\/td><\/tr> <tr><td>2<\/td><td>Ho\u00e0n t\u1ea5t x\u00e1c minh t\u00e0i kho\u1ea3n<\/td><td>H\u1ea7u h\u1ebft n\u1ec1n t\u1ea3ng y\u00eau c\u1ea7u ID v\u00e0 b\u1eb1ng ch\u1ee9ng \u0111\u1ecba ch\u1ec9<\/td><\/tr> <tr><td>3<\/td><td>N\u1ea1p ti\u1ec1n<\/td><td>B\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n b\u1ea1n c\u1ea3m th\u1ea5y tho\u1ea3i m\u00e1i c\u00f3 th\u1ec3 m\u1ea5t<\/td><\/tr> <tr><td>4<\/td><td>T\u00ecm ki\u1ebfm \"OVID\"<\/td><td>S\u1eed d\u1ee5ng m\u00e3 ch\u1ee9ng kho\u00e1n, kh\u00f4ng ch\u1ec9 t\u00ean c\u00f4ng ty<\/td><\/tr> <tr><td>5<\/td><td>Ch\u1ecdn lo\u1ea1i l\u1ec7nh<\/td><td>D\u00f9ng l\u1ec7nh gi\u1edbi h\u1ea1n \u0111\u1ec3 ki\u1ec3m so\u00e1t gi\u00e1 v\u00e0o trong c\u1ed5 phi\u1ebfu bi\u1ebfn \u0111\u1ed9ng<\/td><\/tr> <tr><td>6<\/td><td>Xem l\u1ea1i v\u00e0 x\u00e1c nh\u1eadn<\/td><td>Ki\u1ec3m tra k\u1ef9 s\u1ed1 l\u01b0\u1ee3ng v\u00e0 gi\u00e1 tr\u01b0\u1edbc khi th\u1ef1c hi\u1ec7n<\/td><\/tr> <tr><td>7<\/td><td>Theo d\u00f5i v\u1ecb th\u1ebf c\u1ee7a b\u1ea1n<\/td><td>\u0110\u1eb7t c\u1ea3nh b\u00e1o gi\u00e1 cho c\u00e1c m\u1ee9c bi\u1ebfn \u0111\u1ed9ng l\u1edbn<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 T\u1ea1i Sao Pocket Option Ph\u00f9 H\u1ee3p V\u1edbi Nh\u00e0 \u0110\u1ea7u T\u01b0 C\u00f4ng Ngh\u1ec7 Sinh H\u1ecdc M\u1edbi<\/h2> <p>\u0110\u1ed1i v\u1edbi nh\u1eefng ng\u01b0\u1eddi mu\u1ed1n th\u1eed s\u1ee9c v\u1edbi c\u00e1c c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc bi\u1ebfn \u0111\u1ed9ng nh\u01b0 OVID, Pocket Option cung c\u1ea5p nhi\u1ec1u l\u1ee3i th\u1ebf:<\/p> <ul> <li><strong>S\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u ch\u1ec9 5 USD<\/strong> \u2014 ho\u00e0n h\u1ea3o \u0111\u1ec3 th\u1eed nghi\u1ec7m chi\u1ebfn l\u01b0\u1ee3c v\u1edbi s\u1ed1 ti\u1ec1n nh\u1ecf<\/li> <li><strong>X\u00e1c minh nhanh nh\u01b0 ch\u1edbp<\/strong> \u2014 b\u1eaft \u0111\u1ea7u giao d\u1ecbch trong v\u00e0i ph\u00fat v\u1edbi t\u00e0i li\u1ec7u c\u01a1 b\u1ea3n<\/li> <li><strong>Nhi\u1ec1u l\u1ef1a ch\u1ecdn r\u00fat ti\u1ec1n<\/strong> \u2014 truy c\u1eadp l\u1ee3i nhu\u1eadn qua nhi\u1ec1u ph\u01b0\u01a1ng th\u1ee9c ti\u1ec7n l\u1ee3i<\/li> <\/ul> <p>Giao di\u1ec7n th\u00e2n thi\u1ec7n v\u1edbi ng\u01b0\u1eddi d\u00f9ng c\u1ee7a n\u1ec1n t\u1ea3ng gi\u00fap vi\u1ec7c \u0111i\u1ec1u h\u01b0\u1edbng bi\u1ebfn \u0111\u1ed9ng c\u00f4ng ngh\u1ec7 sinh h\u1ecdc b\u1edbt \u0111\u00e1ng s\u1ee3 h\u01a1n cho ng\u01b0\u1eddi m\u1edbi.<\/p> <h2>\ud83c\udf0d Ovid Therapeutics N\u0103m 2025: Nh\u00e0 \u0110\u1ed5i M\u1edbi Trong Khoa H\u1ecdc Th\u1ea7n Kinh<\/h2> <p>Ovid Therapeutics \u0111\u1ee9ng \u1edf v\u1ecb tr\u00ed ti\u00ean phong trong y h\u1ecdc th\u1ea7n kinh, ph\u00e1t tri\u1ec3n c\u00e1c ph\u01b0\u01a1ng ph\u00e1p \u0111i\u1ec1u tr\u1ecb \u0111\u1ed9t ph\u00e1 cho c\u00e1c b\u1ec7nh l\u00fd \u0111\u00e3 l\u00e0m c\u00e1c b\u00e1c s\u0129 b\u1ed1i r\u1ed1i trong nhi\u1ec1u th\u1eadp k\u1ef7. T\u1eadp trung c\u1ee7a c\u00f4ng ty v\u00e0o c\u00e1c ch\u1ea5t \u1ee9c ch\u1ebf GABA aminotransferase v\u00e0 ch\u1ea5t k\u00edch ho\u1ea1t KCC2 \u0111\u1ea1i di\u1ec7n cho m\u1ed9t trong nh\u1eefng khoa h\u1ecdc h\u1ee9a h\u1eb9n nh\u1ea5t trong l\u0129nh v\u1ef1c h\u1ec7 th\u1ea7n kinh trung \u01b0\u01a1ng.<\/p> <p>V\u1edbi v\u1ed1n h\u00f3a th\u1ecb tr\u01b0\u1eddng kho\u1ea3ng 60 tri\u1ec7u USD, OVID v\u1eabn l\u00e0 vi\u00ean ng\u1ecdc nh\u1ecf v\u1edbi ti\u1ec1m n\u0103ng l\u1edbn. S\u1ef1 b\u00f9ng n\u1ed5 doanh thu g\u1ea7n \u0111\u00e2y c\u1ee7a c\u00f4ng ty \u2014 t\u1eeb 0,17 tri\u1ec7u USD l\u00ean 6,27 tri\u1ec7u USD trong m\u1ed9t n\u0103m \u2014 cho th\u1ea5y m\u00f4 h\u00ecnh kinh doanh \u0111ang \u0111\u01b0\u1ee3c \u0111\u00f3n nh\u1eadn (<a href=\"https:\/\/investors.ovidrx.com\/news\/news-details\/2025\/Ovid-Therapeutics-Reports-Business-Updates-and-Second-Quarter-2025-Financial-Results\/default.aspx\">B\u00e1o c\u00e1o ch\u00ednh th\u1ee9c cho nh\u00e0 \u0111\u1ea7u t\u01b0<\/a>).<\/p> <p><strong>S\u1ef1 th\u1eadt th\u00fa v\u1ecb<\/strong>: N\u0103m 2025, nh\u00f3m nghi\u00ean c\u1ee9u c\u1ee7a Ovid ph\u00e1t hi\u1ec7n ra r\u1eb1ng h\u1ee3p ch\u1ea5t ch\u1ee7 l\u1ef1c OV329 kh\u00f4ng ch\u1ec9 gi\u1ea3m c\u00e1c c\u01a1n co gi\u1eadt m\u00e0 c\u00f2n c\u00f3 v\u1ebb c\u1ea3i thi\u1ec7n ch\u1ee9c n\u0103ng nh\u1eadn th\u1ee9c trong c\u00e1c m\u00f4 h\u00ecnh ti\u1ec1n l\u00e2m s\u00e0ng \u2014 m\u1ed9t l\u1ee3i \u00edch k\u00e9p ti\u1ec1m n\u0103ng c\u00f3 th\u1ec3 c\u00e1ch m\u1ea1ng h\u00f3a \u0111i\u1ec1u tr\u1ecb \u0111\u1ed9ng kinh!<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 C\u1ed5 Phi\u1ebfu Ovid Therapeutics: Gi\u00e1 Hi\u1ec7n T\u1ea1i v\u00e0 C\u00e1c Ng\u00e0y Quan Tr\u1ecdng<\/h2>\n<p>T\u00ednh \u0111\u1ebfn ng\u00e0y 25 th\u00e1ng 8 n\u0103m 2025, Ovid Therapeutics Inc. (OVID) giao d\u1ecbch \u1edf m\u1ee9c <strong>1,03 USD<\/strong> m\u1ed7i c\u1ed5 phi\u1ebfu. Nh\u01b0ng h\u00e3y \u0111\u00e1nh d\u1ea5u l\u1ecbch c\u1ee7a b\u1ea1n: <strong>Th\u00e1ng 11 n\u0103m 2025<\/strong> c\u00f3 th\u1ec3 l\u00e0 th\u1eddi \u0111i\u1ec3m b\u00f9ng n\u1ed5 cho c\u1ed5 phi\u1ebfu n\u00e0y. \u0110\u00f3 l\u00e0 khi c\u00f4ng ty d\u1ef1 ki\u1ebfn s\u1ebd c\u00f4ng b\u1ed1 b\u00e1o c\u00e1o thu nh\u1eadp ti\u1ebfp theo, v\u00e0 d\u1ef1a tr\u00ean l\u1ecbch s\u1eed g\u1ea7n \u0111\u00e2y, nh\u1eefng s\u1ef1 ki\u1ec7n n\u00e0y \u0111\u00e3 khi\u1ebfn OVID bi\u1ebfn \u0111\u1ed9ng m\u1ea1nh m\u1ebd.<\/p>\n<h3>C\u00e1ch B\u00e1o C\u00e1o Thu Nh\u1eadp \u1ea2nh H\u01b0\u1edfng \u0110\u1ebfn C\u1ed5 Phi\u1ebfu OVID<\/h3>\n<p>B\u00e1o c\u00e1o thu nh\u1eadp g\u1ea7n nh\u1ea5t v\u00e0o ng\u00e0y 13 th\u00e1ng 8 n\u0103m 2025 \u0111\u00e3 t\u1ea1o ra l\u00e0n s\u00f3ng ch\u1ea5n \u0111\u1ed9ng tr\u00ean th\u1ecb tr\u01b0\u1eddng. C\u00f4ng ty b\u00e1o c\u00e1o doanh thu 6,27 tri\u1ec7u USD \u2014 t\u0103ng m\u1ea1nh <strong>3.611%<\/strong> so v\u1edbi c\u00f9ng k\u1ef3 n\u0103m tr\u01b0\u1edbc! M\u1eb7c d\u00f9 ghi nh\u1eadn l\u1ed7 r\u00f2ng 4,68 tri\u1ec7u USD do chi ti\u00eau R&#038;D t\u0103ng cao, c\u1ed5 phi\u1ebfu \u0111\u00e3 t\u0103ng v\u1ecdt <strong>52,61%<\/strong> trong phi\u00ean giao d\u1ecbch ti\u1ebfp theo (<a href=\"https:\/\/www.ainvest.com\/news\/ovid-therapeutics-reports-q2-2025-financials-7mln-royalty-deal-q3-2025-results-expected-2508\/\">B\u00e1o c\u00e1o AInvest<\/a>).<\/p>\n<p>M\u1eabu h\u00ecnh n\u00e0y kh\u00f4ng ph\u1ea3i l\u00e0 m\u1edbi. C\u00e1c c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc nh\u01b0 OVID s\u1ed1ng v\u00e0 ch\u1ebft d\u1ef1a v\u00e0o k\u1ebft qu\u1ea3 th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng v\u00e0 c\u00e1c b\u1ea5t ng\u1edd v\u1ec1 thu nh\u1eadp. B\u00e1o c\u00e1o th\u00e1ng 11 s\u1eafp t\u1edbi c\u00f3 th\u1ec3 c\u0169ng s\u1ebd r\u1ea5t k\u1ecbch t\u00ednh, \u0111\u1eb7c bi\u1ec7t v\u1edbi c\u00e1c d\u1eef li\u1ec7u quan tr\u1ecdng d\u1ef1 ki\u1ebfn cho ph\u01b0\u01a1ng ph\u00e1p \u0111i\u1ec1u tr\u1ecb OV329 c\u1ee7a h\u1ecd.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/vt\/register\/\" class=\"po-cta-green\">B\u1eaft \u0111\u1ea7u giao d\u1ecbch\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udd0d H\u00e0nh Tr\u00ecnh Gi\u00e1 6 Th\u00e1ng: C\u1ea3m Gi\u00e1c T\u00e0u L\u01b0\u1ee3n Si\u00eau T\u1ed1c<\/h2>\n<p>Di\u1ec5n bi\u1ebfn gi\u00e1 c\u1ee7a OVID trong s\u00e1u th\u00e1ng qua th\u1eadt s\u1ef1 ngo\u1ea1n m\u1ee5c:<\/p>\n<ul>\n<li><strong>Th\u00e1ng 2-3 n\u0103m 2025<\/strong>: C\u1ed5 phi\u1ebfu giao d\u1ecbch trong kho\u1ea3ng 0,60-0,70 USD, th\u1ec3 hi\u1ec7n s\u1ef1 bi\u1ebfn \u0111\u1ed9ng \u0111i\u1ec3n h\u00ecnh c\u1ee7a c\u00f4ng ngh\u1ec7 sinh h\u1ecdc<\/li>\n<li><strong>Th\u00e1ng 4-6 n\u0103m 2025<\/strong>: Gi\u1ea3m d\u1ea7n xu\u1ed1ng kho\u1ea3ng 0,24-0,40 USD \u2014 giai \u0111o\u1ea1n &#8220;ch\u1edd \u0111\u1ee3i&#8221; tr\u01b0\u1edbc c\u00e1c ch\u1ea5t x\u00fac t\u00e1c l\u1edbn<\/li>\n<li><strong>Th\u00e1ng 7 n\u0103m 2025<\/strong>: Di chuy\u1ec3n b\u00f9ng n\u1ed5 v\u1edbi bi\u1ebfn \u0111\u1ed9ng trung b\u00ecnh h\u00e0ng ng\u00e0y <strong>11,15%<\/strong>, bao g\u1ed3m dao \u0111\u1ed9ng trong ng\u00e0y 14,79%<\/li>\n<li><strong>Th\u00e1ng 8 n\u0103m 2025<\/strong>: B\u1ee9t ph\u00e1 l\u1edbn \u2014 t\u0103ng <strong>163,59%<\/strong> trong m\u1ed9t th\u00e1ng sau b\u00e1o c\u00e1o thu nh\u1eadp t\u00edch c\u1ef1c v\u00e0 c\u1eadp nh\u1eadt l\u00e2m s\u00e0ng<\/li>\n<\/ul>\n<p>T\u1ea1i sao l\u1ea1i c\u00f3 nh\u1eefng bi\u1ebfn \u0111\u1ed9ng m\u1ea1nh nh\u01b0 v\u1eady? OVID \u0111\u1ea1i di\u1ec7n cho b\u1ea3n ch\u1ea5t thu\u1ea7n t\u00fay c\u1ee7a \u0111\u1ea7u t\u01b0 c\u00f4ng ngh\u1ec7 sinh h\u1ecdc: r\u1ee7i ro cao, ph\u1ea7n th\u01b0\u1edfng cao. C\u1ed5 phi\u1ebfu \u0111\u00e3 ch\u1ea1m \u0111\u00e1y 52 tu\u1ea7n \u1edf m\u1ee9c <strong>0,24 USD<\/strong> v\u00e0 \u0111\u1ec9nh 52 tu\u1ea7n \u1edf m\u1ee9c <strong>1,47 USD<\/strong> trong kho\u1ea3ng th\u1eddi gian n\u00e0y, cho th\u1ea5y ti\u1ec1m n\u0103ng bi\u00ean \u0111\u1ed9 c\u1ef1c l\u1edbn (<a href=\"https:\/\/stockinvest.us\/stock\/OVID\">D\u1eef li\u1ec7u StockInvest<\/a>).<\/p>\n<h2>\ud83d\udd2e D\u1ef1 B\u00e1o Gi\u00e1: Tri\u1ec3n V\u1ecdng 2025-2030<\/h2>\n<ul>\n<li><strong>Cu\u1ed1i n\u0103m 2025<\/strong>: Kho\u1ea3ng 3,10-7,14 USD (ti\u1ec1m n\u0103ng t\u0103ng 200-578%) \u2192 <strong>MUA M\u1ea0NH<\/strong><br \/> C\u00e1c nh\u00e0 ph\u00e2n t\u00edch r\u1ea5t l\u1ea1c quan, v\u1edbi m\u1ee5c ti\u00eau gi\u00e1 trung b\u00ecnh l\u00e0 3,10 USD v\u00e0 c\u00e1c m\u00f4 h\u00ecnh k\u1ef9 thu\u1eadt d\u1ef1 \u0111o\u00e1n l\u00ean \u0111\u1ebfn 7,14 USD (<a href=\"https:\/\/stockscan.io\/stocks\/OVID\/forecast\">D\u1ef1 b\u00e1o StockScan<\/a>). Ch\u1ea5t x\u00fac t\u00e1c ch\u00ednh? D\u1eef li\u1ec7u giai \u0111o\u1ea1n 1 c\u1ee7a OV329 d\u1ef1 ki\u1ebfn trong qu\u00fd 3 n\u0103m 2025.<\/li>\n<li><strong>D\u1ef1 b\u00e1o 2026<\/strong>: Kho\u1ea3ng 0,495-3,50 USD<br \/> S\u1ef1 ph\u00e2n k\u1ef3 \u1edf \u0111\u00e2y ph\u1ea3n \u00e1nh t\u00ednh nh\u1ecb ph\u00e2n c\u1ee7a c\u00f4ng ngh\u1ec7 sinh h\u1ecdc \u2014 ho\u1eb7c th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng th\u00e0nh c\u00f4ng (kho\u1ea3ng cao h\u01a1n) ho\u1eb7c g\u1eb7p kh\u00f3 kh\u0103n (kho\u1ea3ng th\u1ea5p h\u01a1n).<\/li>\n<li><strong>D\u1ef1 b\u00e1o 2028<\/strong>: 0,225-1,00 USD<br \/> C\u00e1c m\u00f4 h\u00ecnh d\u00e0i h\u1ea1n cho th\u1ea5y \u01b0\u1edbc t\u00ednh th\u1eadn tr\u1ecdng, nh\u01b0ng vi\u1ec7c ph\u00ea duy\u1ec7t thu\u1ed1c th\u00e0nh c\u00f4ng c\u00f3 th\u1ec3 thay \u0111\u1ed5i \u0111\u00e1ng k\u1ec3 tri\u1ec3n v\u1ecdng n\u00e0y.<\/li>\n<li><strong>Tri\u1ec3n v\u1ecdng 2030<\/strong>: R\u1ea5t mang t\u00ednh \u0111\u1ea7u c\u01a1<br \/> \u0110\u1ebfn n\u0103m 2030, n\u1ebfu OVID c\u00f3 th\u1ec3 \u0111\u01b0a ra \u00edt nh\u1ea5t m\u1ed9t lo\u1ea1i thu\u1ed1c \u0111\u01b0\u1ee3c ph\u00ea duy\u1ec7t, c\u1ed5 phi\u1ebfu c\u00f3 th\u1ec3 t\u0103ng l\u00ean \u0111\u00e1ng k\u1ec3. Tuy nhi\u00ean, \u0111\u00e2y v\u1eabn l\u00e0 ph\u1ea7n r\u1ee7i ro nh\u1ea5t trong d\u1ef1 b\u00e1o.<\/li>\n<\/ul>\n<h2>\u26a0\ufe0f R\u1ee7i Ro Ch\u00ednh v\u00e0 T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c<\/h2>\n<h3>R\u1ee7i ro c\u1ea7n c\u00e2n nh\u1eafc:<\/h3>\n<ul>\n<li><strong>Ti\u00eau ti\u1ec1n m\u1eb7t<\/strong>: D\u01b0\u1edbi m\u1ed9t n\u0103m d\u00f2ng ti\u1ec1n ho\u1ea1t \u0111\u1ed9ng m\u1eb7c d\u00f9 c\u00f3 38,3 tri\u1ec7u USD ti\u1ec1n m\u1eb7t<\/li>\n<li><strong>Th\u1ea5t b\u1ea1i th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng<\/strong>: D\u1eef li\u1ec7u giai \u0111o\u1ea1n 1 c\u1ee7a OV329 c\u00f3 th\u1ec3 l\u00e0m nh\u00e0 \u0111\u1ea7u t\u01b0 th\u1ea5t v\u1ecdng<\/li>\n<li><strong>Bi\u1ebfn \u0111\u1ed9ng c\u1ef1c \u0111oan<\/strong>: Dao \u0111\u1ed9ng trung b\u00ecnh h\u00e0ng ng\u00e0y 11,15% c\u00f3 th\u1ec3 th\u1eed th\u00e1ch s\u1ef1 ki\u00ean nh\u1eabn c\u1ee7a b\u1ea5t k\u1ef3 nh\u00e0 \u0111\u1ea7u t\u01b0 n\u00e0o<\/li>\n<li><strong>R\u1ee7i ro pha lo\u00e3ng<\/strong>: Kh\u1ea3 n\u0103ng cao s\u1ebd c\u00f3 th\u00eam c\u00e1c \u0111\u1ee3t ph\u00e1t h\u00e0nh c\u1ed5 phi\u1ebfu \u0111\u1ec3 t\u00e0i tr\u1ee3 ho\u1ea1t \u0111\u1ed9ng<\/li>\n<\/ul>\n<h3>T\u00edn hi\u1ec7u t\u00edch c\u1ef1c cho n\u0103m 2025:<\/h3>\n<ul>\n<li><strong>Doanh thu b\u00f9ng n\u1ed5<\/strong>: T\u0103ng tr\u01b0\u1edfng 3.611% so v\u1edbi c\u00f9ng k\u1ef3 n\u0103m tr\u01b0\u1edbc cho th\u1ea5y ti\u1ec1m n\u0103ng m\u00f4 h\u00ecnh kinh doanh<\/li>\n<li><strong>Ti\u1ebfn tri\u1ec3n trong danh m\u1ee5c s\u1ea3n ph\u1ea9m<\/strong>: D\u1eef li\u1ec7u giai \u0111o\u1ea1n 1 c\u1ee7a OV329 d\u1ef1 ki\u1ebfn qu\u00fd 3 n\u0103m 2025 \u2014 ch\u1ea5t x\u00fac t\u00e1c l\u1edbn<\/li>\n<li><strong>Th\u1ecfa thu\u1eadn chi\u1ebfn l\u01b0\u1ee3c<\/strong>: H\u1ee3p \u0111\u1ed3ng b\u1ea3n quy\u1ec1n 7 tri\u1ec7u USD v\u1edbi Immedica k\u00e9o d\u00e0i d\u00f2ng ti\u1ec1n<\/li>\n<li><strong>Xu h\u01b0\u1edbng ng\u00e0nh<\/strong>: \u0110i\u1ec1u tr\u1ecb r\u1ed1i lo\u1ea1n h\u1ec7 th\u1ea7n kinh trung \u01b0\u01a1ng \u0111\u1ea1i di\u1ec7n cho c\u01a1 h\u1ed9i th\u1ecb tr\u01b0\u1eddng tr\u00ean 150 t\u1ef7 USD<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Nh\u00e0 Giao D\u1ecbch M\u1edbi N\u00ean L\u00e0m G\u00ec H\u00f4m Nay?<\/h2>\n<ol>\n<li><strong>B\u1eaft \u0111\u1ea7u nh\u1ecf<\/strong>: Ph\u00e2n b\u1ed5 kh\u00f4ng qu\u00e1 2-5% danh m\u1ee5c \u0111\u1ea7u t\u01b0 v\u00e0o c\u00f4ng ngh\u1ec7 sinh h\u1ecdc r\u1ee7i ro cao nh\u01b0 OVID<\/li>\n<li><strong>Trung b\u00ecnh gi\u00e1<\/strong>: Mua t\u1eebng ph\u1ea7n nh\u1ecf thay v\u00ec mua m\u1ed9t l\u1ea7n l\u1edbn<\/li>\n<li><strong>\u0110\u1eb7t l\u1ec7nh d\u1eebng l\u1ed7<\/strong>: B\u1ea3o v\u1ec7 b\u1ea3n th\u00e2n kh\u1ecfi bi\u1ebfn \u0111\u1ed9ng gi\u1ea3m m\u1ea1nh<\/li>\n<li><strong>Theo d\u00f5i c\u00e1c ch\u1ea5t x\u00fac t\u00e1c<\/strong>: \u0110\u00e1nh d\u1ea5u ng\u00e0y b\u00e1o c\u00e1o thu nh\u1eadp th\u00e1ng 11 n\u0103m 2025 v\u00e0 d\u1eef li\u1ec7u l\u00e2m s\u00e0ng qu\u00fd 3<\/li>\n<\/ol>\n<p>Ch\u00e2m bi\u1ebfm: &#8220;Giao d\u1ecbch OVID gi\u1ed1ng nh\u01b0 h\u1eb9n h\u00f2 v\u1edbi m\u1ed9t nh\u00e0 th\u1ea7n kinh h\u1ecdc \u2014 ti\u1ec1m n\u0103ng tuy\u1ec7t v\u1eddi, c\u1ea3m x\u00fac kh\u00f3 \u0111o\u00e1n v\u00e0 c\u1ea7n thu\u1ed1c d\u1ea1 d\u00e0y m\u1ea1nh!&#8221;<\/p>\n<h2>\u2705 C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Ovid Therapeutics Inc. (OVID) &#8211; T\u1eebng B\u01b0\u1edbc<\/h2>\n<table>\n<thead>\n<tr>\n<th>B\u01b0\u1edbc<\/th>\n<th>H\u00e0nh \u0110\u1ed9ng<\/th>\n<th>T\u1ea1i Sao Quan Tr\u1ecdng<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Ch\u1ecdn n\u1ec1n t\u1ea3ng giao d\u1ecbch<\/td>\n<td>\u0110\u1ea3m b\u1ea3o n\u1ec1n t\u1ea3ng c\u00f3 truy c\u1eadp NASDAQ v\u00e0 c\u00f3 c\u1ed5 phi\u1ebfu OVID<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Ho\u00e0n t\u1ea5t x\u00e1c minh t\u00e0i kho\u1ea3n<\/td>\n<td>H\u1ea7u h\u1ebft n\u1ec1n t\u1ea3ng y\u00eau c\u1ea7u ID v\u00e0 b\u1eb1ng ch\u1ee9ng \u0111\u1ecba ch\u1ec9<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>N\u1ea1p ti\u1ec1n<\/td>\n<td>B\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n b\u1ea1n c\u1ea3m th\u1ea5y tho\u1ea3i m\u00e1i c\u00f3 th\u1ec3 m\u1ea5t<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>T\u00ecm ki\u1ebfm &#8220;OVID&#8221;<\/td>\n<td>S\u1eed d\u1ee5ng m\u00e3 ch\u1ee9ng kho\u00e1n, kh\u00f4ng ch\u1ec9 t\u00ean c\u00f4ng ty<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Ch\u1ecdn lo\u1ea1i l\u1ec7nh<\/td>\n<td>D\u00f9ng l\u1ec7nh gi\u1edbi h\u1ea1n \u0111\u1ec3 ki\u1ec3m so\u00e1t gi\u00e1 v\u00e0o trong c\u1ed5 phi\u1ebfu bi\u1ebfn \u0111\u1ed9ng<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Xem l\u1ea1i v\u00e0 x\u00e1c nh\u1eadn<\/td>\n<td>Ki\u1ec3m tra k\u1ef9 s\u1ed1 l\u01b0\u1ee3ng v\u00e0 gi\u00e1 tr\u01b0\u1edbc khi th\u1ef1c hi\u1ec7n<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Theo d\u00f5i v\u1ecb th\u1ebf c\u1ee7a b\u1ea1n<\/td>\n<td>\u0110\u1eb7t c\u1ea3nh b\u00e1o gi\u00e1 cho c\u00e1c m\u1ee9c bi\u1ebfn \u0111\u1ed9ng l\u1edbn<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 T\u1ea1i Sao Pocket Option Ph\u00f9 H\u1ee3p V\u1edbi Nh\u00e0 \u0110\u1ea7u T\u01b0 C\u00f4ng Ngh\u1ec7 Sinh H\u1ecdc M\u1edbi<\/h2>\n<p>\u0110\u1ed1i v\u1edbi nh\u1eefng ng\u01b0\u1eddi mu\u1ed1n th\u1eed s\u1ee9c v\u1edbi c\u00e1c c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc bi\u1ebfn \u0111\u1ed9ng nh\u01b0 OVID, Pocket Option cung c\u1ea5p nhi\u1ec1u l\u1ee3i th\u1ebf:<\/p>\n<ul>\n<li><strong>S\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u ch\u1ec9 5 USD<\/strong> \u2014 ho\u00e0n h\u1ea3o \u0111\u1ec3 th\u1eed nghi\u1ec7m chi\u1ebfn l\u01b0\u1ee3c v\u1edbi s\u1ed1 ti\u1ec1n nh\u1ecf<\/li>\n<li><strong>X\u00e1c minh nhanh nh\u01b0 ch\u1edbp<\/strong> \u2014 b\u1eaft \u0111\u1ea7u giao d\u1ecbch trong v\u00e0i ph\u00fat v\u1edbi t\u00e0i li\u1ec7u c\u01a1 b\u1ea3n<\/li>\n<li><strong>Nhi\u1ec1u l\u1ef1a ch\u1ecdn r\u00fat ti\u1ec1n<\/strong> \u2014 truy c\u1eadp l\u1ee3i nhu\u1eadn qua nhi\u1ec1u ph\u01b0\u01a1ng th\u1ee9c ti\u1ec7n l\u1ee3i<\/li>\n<\/ul>\n<p>Giao di\u1ec7n th\u00e2n thi\u1ec7n v\u1edbi ng\u01b0\u1eddi d\u00f9ng c\u1ee7a n\u1ec1n t\u1ea3ng gi\u00fap vi\u1ec7c \u0111i\u1ec1u h\u01b0\u1edbng bi\u1ebfn \u0111\u1ed9ng c\u00f4ng ngh\u1ec7 sinh h\u1ecdc b\u1edbt \u0111\u00e1ng s\u1ee3 h\u01a1n cho ng\u01b0\u1eddi m\u1edbi.<\/p>\n<h2>\ud83c\udf0d Ovid Therapeutics N\u0103m 2025: Nh\u00e0 \u0110\u1ed5i M\u1edbi Trong Khoa H\u1ecdc Th\u1ea7n Kinh<\/h2>\n<p>Ovid Therapeutics \u0111\u1ee9ng \u1edf v\u1ecb tr\u00ed ti\u00ean phong trong y h\u1ecdc th\u1ea7n kinh, ph\u00e1t tri\u1ec3n c\u00e1c ph\u01b0\u01a1ng ph\u00e1p \u0111i\u1ec1u tr\u1ecb \u0111\u1ed9t ph\u00e1 cho c\u00e1c b\u1ec7nh l\u00fd \u0111\u00e3 l\u00e0m c\u00e1c b\u00e1c s\u0129 b\u1ed1i r\u1ed1i trong nhi\u1ec1u th\u1eadp k\u1ef7. T\u1eadp trung c\u1ee7a c\u00f4ng ty v\u00e0o c\u00e1c ch\u1ea5t \u1ee9c ch\u1ebf GABA aminotransferase v\u00e0 ch\u1ea5t k\u00edch ho\u1ea1t KCC2 \u0111\u1ea1i di\u1ec7n cho m\u1ed9t trong nh\u1eefng khoa h\u1ecdc h\u1ee9a h\u1eb9n nh\u1ea5t trong l\u0129nh v\u1ef1c h\u1ec7 th\u1ea7n kinh trung \u01b0\u01a1ng.<\/p>\n<p>V\u1edbi v\u1ed1n h\u00f3a th\u1ecb tr\u01b0\u1eddng kho\u1ea3ng 60 tri\u1ec7u USD, OVID v\u1eabn l\u00e0 vi\u00ean ng\u1ecdc nh\u1ecf v\u1edbi ti\u1ec1m n\u0103ng l\u1edbn. S\u1ef1 b\u00f9ng n\u1ed5 doanh thu g\u1ea7n \u0111\u00e2y c\u1ee7a c\u00f4ng ty \u2014 t\u1eeb 0,17 tri\u1ec7u USD l\u00ean 6,27 tri\u1ec7u USD trong m\u1ed9t n\u0103m \u2014 cho th\u1ea5y m\u00f4 h\u00ecnh kinh doanh \u0111ang \u0111\u01b0\u1ee3c \u0111\u00f3n nh\u1eadn (<a href=\"https:\/\/investors.ovidrx.com\/news\/news-details\/2025\/Ovid-Therapeutics-Reports-Business-Updates-and-Second-Quarter-2025-Financial-Results\/default.aspx\">B\u00e1o c\u00e1o ch\u00ednh th\u1ee9c cho nh\u00e0 \u0111\u1ea7u t\u01b0<\/a>).<\/p>\n<p><strong>S\u1ef1 th\u1eadt th\u00fa v\u1ecb<\/strong>: N\u0103m 2025, nh\u00f3m nghi\u00ean c\u1ee9u c\u1ee7a Ovid ph\u00e1t hi\u1ec7n ra r\u1eb1ng h\u1ee3p ch\u1ea5t ch\u1ee7 l\u1ef1c OV329 kh\u00f4ng ch\u1ec9 gi\u1ea3m c\u00e1c c\u01a1n co gi\u1eadt m\u00e0 c\u00f2n c\u00f3 v\u1ebb c\u1ea3i thi\u1ec7n ch\u1ee9c n\u0103ng nh\u1eadn th\u1ee9c trong c\u00e1c m\u00f4 h\u00ecnh ti\u1ec1n l\u00e2m s\u00e0ng \u2014 m\u1ed9t l\u1ee3i \u00edch k\u00e9p ti\u1ec1m n\u0103ng c\u00f3 th\u1ec3 c\u00e1ch m\u1ea1ng h\u00f3a \u0111i\u1ec1u tr\u1ecb \u0111\u1ed9ng kinh!<\/p>\n"},"faq":[{"question":"Ovid Therapeutics Inc. (OVID) l\u00e0 c\u00f4ng ty g\u00ec?","answer":"Ovid Therapeutics Inc. l\u00e0 m\u1ed9t c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc chuy\u00ean ph\u00e1t tri\u1ec3n c\u00e1c ph\u01b0\u01a1ng ph\u00e1p \u0111i\u1ec1u tr\u1ecb \u0111\u1ed9t ph\u00e1 cho c\u00e1c r\u1ed1i lo\u1ea1n th\u1ea7n kinh trung \u01b0\u01a1ng, t\u1eadp trung v\u00e0o c\u00e1c ch\u1ea5t \u1ee9c ch\u1ebf GABA aminotransferase v\u00e0 ch\u1ea5t k\u00edch ho\u1ea1t KCC2."},{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 mua c\u1ed5 phi\u1ebfu OVID?","answer":"B\u1ea1n c\u00f3 th\u1ec3 mua c\u1ed5 phi\u1ebfu OVID th\u00f4ng qua c\u00e1c n\u1ec1n t\u1ea3ng giao d\u1ecbch c\u00f3 truy c\u1eadp NASDAQ, th\u1ef1c hi\u1ec7n c\u00e1c b\u01b0\u1edbc nh\u01b0 x\u00e1c minh t\u00e0i kho\u1ea3n, n\u1ea1p ti\u1ec1n, t\u00ecm ki\u1ebfm m\u00e3 c\u1ed5 phi\u1ebfu OVID, ch\u1ecdn lo\u1ea1i l\u1ec7nh v\u00e0 x\u00e1c nh\u1eadn giao d\u1ecbch."},{"question":"R\u1ee7i ro ch\u00ednh khi \u0111\u1ea7u t\u01b0 v\u00e0o OVID l\u00e0 g\u00ec?","answer":"C\u00e1c r\u1ee7i ro ch\u00ednh bao g\u1ed3m ti\u00eau ti\u1ec1n m\u1eb7t nhanh, kh\u1ea3 n\u0103ng th\u1ea5t b\u1ea1i trong th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng, bi\u1ebfn \u0111\u1ed9ng gi\u00e1 c\u1ed5 phi\u1ebfu cao v\u00e0 r\u1ee7i ro pha lo\u00e3ng c\u1ed5 phi\u1ebfu do ph\u00e1t h\u00e0nh th\u00eam."},{"question":"D\u1ef1 b\u00e1o gi\u00e1 c\u1ed5 phi\u1ebfu OVID trong t\u01b0\u01a1ng lai nh\u01b0 th\u1ebf n\u00e0o?","answer":"D\u1ef1 b\u00e1o gi\u00e1 cho n\u0103m 2025 \u0111\u1ebfn 2030 r\u1ea5t bi\u1ebfn \u0111\u1ed9ng, v\u1edbi m\u1ee9c gi\u00e1 c\u00f3 th\u1ec3 dao \u0111\u1ed9ng t\u1eeb 0,225 USD \u0111\u1ebfn h\u01a1n 7 USD t\u00f9y thu\u1ed9c v\u00e0o th\u00e0nh c\u00f4ng c\u1ee7a c\u00e1c th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng v\u00e0 ph\u00ea duy\u1ec7t thu\u1ed1c."},{"question":"T\u1ea1i sao n\u00ean s\u1eed d\u1ee5ng Pocket Option \u0111\u1ec3 \u0111\u1ea7u t\u01b0 v\u00e0o OVID?","answer":"Pocket Option ph\u00f9 h\u1ee3p v\u1edbi nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi nh\u1edd s\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u th\u1ea5p, x\u00e1c minh nhanh ch\u00f3ng v\u00e0 nhi\u1ec1u l\u1ef1a ch\u1ecdn r\u00fat ti\u1ec1n, gi\u00fap d\u1ec5 d\u00e0ng ti\u1ebfp c\u1eadn c\u00e1c c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc bi\u1ebfn \u0111\u1ed9ng nh\u01b0 OVID."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Ovid Therapeutics Inc. (OVID) l\u00e0 c\u00f4ng ty g\u00ec?","answer":"Ovid Therapeutics Inc. l\u00e0 m\u1ed9t c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc chuy\u00ean ph\u00e1t tri\u1ec3n c\u00e1c ph\u01b0\u01a1ng ph\u00e1p \u0111i\u1ec1u tr\u1ecb \u0111\u1ed9t ph\u00e1 cho c\u00e1c r\u1ed1i lo\u1ea1n th\u1ea7n kinh trung \u01b0\u01a1ng, t\u1eadp trung v\u00e0o c\u00e1c ch\u1ea5t \u1ee9c ch\u1ebf GABA aminotransferase v\u00e0 ch\u1ea5t k\u00edch ho\u1ea1t KCC2."},{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 mua c\u1ed5 phi\u1ebfu OVID?","answer":"B\u1ea1n c\u00f3 th\u1ec3 mua c\u1ed5 phi\u1ebfu OVID th\u00f4ng qua c\u00e1c n\u1ec1n t\u1ea3ng giao d\u1ecbch c\u00f3 truy c\u1eadp NASDAQ, th\u1ef1c hi\u1ec7n c\u00e1c b\u01b0\u1edbc nh\u01b0 x\u00e1c minh t\u00e0i kho\u1ea3n, n\u1ea1p ti\u1ec1n, t\u00ecm ki\u1ebfm m\u00e3 c\u1ed5 phi\u1ebfu OVID, ch\u1ecdn lo\u1ea1i l\u1ec7nh v\u00e0 x\u00e1c nh\u1eadn giao d\u1ecbch."},{"question":"R\u1ee7i ro ch\u00ednh khi \u0111\u1ea7u t\u01b0 v\u00e0o OVID l\u00e0 g\u00ec?","answer":"C\u00e1c r\u1ee7i ro ch\u00ednh bao g\u1ed3m ti\u00eau ti\u1ec1n m\u1eb7t nhanh, kh\u1ea3 n\u0103ng th\u1ea5t b\u1ea1i trong th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng, bi\u1ebfn \u0111\u1ed9ng gi\u00e1 c\u1ed5 phi\u1ebfu cao v\u00e0 r\u1ee7i ro pha lo\u00e3ng c\u1ed5 phi\u1ebfu do ph\u00e1t h\u00e0nh th\u00eam."},{"question":"D\u1ef1 b\u00e1o gi\u00e1 c\u1ed5 phi\u1ebfu OVID trong t\u01b0\u01a1ng lai nh\u01b0 th\u1ebf n\u00e0o?","answer":"D\u1ef1 b\u00e1o gi\u00e1 cho n\u0103m 2025 \u0111\u1ebfn 2030 r\u1ea5t bi\u1ebfn \u0111\u1ed9ng, v\u1edbi m\u1ee9c gi\u00e1 c\u00f3 th\u1ec3 dao \u0111\u1ed9ng t\u1eeb 0,225 USD \u0111\u1ebfn h\u01a1n 7 USD t\u00f9y thu\u1ed9c v\u00e0o th\u00e0nh c\u00f4ng c\u1ee7a c\u00e1c th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng v\u00e0 ph\u00ea duy\u1ec7t thu\u1ed1c."},{"question":"T\u1ea1i sao n\u00ean s\u1eed d\u1ee5ng Pocket Option \u0111\u1ec3 \u0111\u1ea7u t\u01b0 v\u00e0o OVID?","answer":"Pocket Option ph\u00f9 h\u1ee3p v\u1edbi nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi nh\u1edd s\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u th\u1ea5p, x\u00e1c minh nhanh ch\u00f3ng v\u00e0 nhi\u1ec1u l\u1ef1a ch\u1ecdn r\u00fat ti\u1ec1n, gi\u00fap d\u1ec5 d\u00e0ng ti\u1ebfp c\u1eadn c\u00e1c c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc bi\u1ebfn \u0111\u1ed9ng nh\u01b0 OVID."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>C\u00e1ch mua c\u1ed5 phi\u1ebfu Ovid Therapeutics Inc. (OVID) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Ovid Therapeutics Inc. (OVID)<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ovid-therapeutics\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Ovid Therapeutics Inc. (OVID) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Ovid Therapeutics Inc. (OVID)\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ovid-therapeutics\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-25T12:50:54+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ovid-therapeutics\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ovid-therapeutics\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Ovid Therapeutics Inc. (OVID) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Ovid Therapeutics Inc. (OVID)\",\"datePublished\":\"2025-08-25T12:50:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ovid-therapeutics\/\"},\"wordCount\":23,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ovid-therapeutics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals15-scaled.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ovid-therapeutics\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ovid-therapeutics\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ovid-therapeutics\/\",\"name\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Ovid Therapeutics Inc. (OVID) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Ovid Therapeutics Inc. (OVID)\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ovid-therapeutics\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ovid-therapeutics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals15-scaled.webp\",\"datePublished\":\"2025-08-25T12:50:54+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ovid-therapeutics\/#breadcrumb\"},\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ovid-therapeutics\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ovid-therapeutics\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals15-scaled.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals15-scaled.webp\",\"width\":2560,\"height\":1429},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ovid-therapeutics\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/vt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Ovid Therapeutics Inc. (OVID) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Ovid Therapeutics Inc. (OVID)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"vt-VT\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Ovid Therapeutics Inc. (OVID) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Ovid Therapeutics Inc. (OVID)","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ovid-therapeutics\/","og_locale":"en_US","og_type":"article","og_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Ovid Therapeutics Inc. (OVID) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Ovid Therapeutics Inc. (OVID)","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ovid-therapeutics\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-25T12:50:54+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ovid-therapeutics\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ovid-therapeutics\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Ovid Therapeutics Inc. (OVID) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Ovid Therapeutics Inc. (OVID)","datePublished":"2025-08-25T12:50:54+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ovid-therapeutics\/"},"wordCount":23,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ovid-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals15-scaled.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"vt-VT","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ovid-therapeutics\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ovid-therapeutics\/","url":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ovid-therapeutics\/","name":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Ovid Therapeutics Inc. (OVID) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Ovid Therapeutics Inc. (OVID)","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ovid-therapeutics\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ovid-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals15-scaled.webp","datePublished":"2025-08-25T12:50:54+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ovid-therapeutics\/#breadcrumb"},"inLanguage":"vt-VT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ovid-therapeutics\/"]}]},{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ovid-therapeutics\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals15-scaled.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals15-scaled.webp","width":2560,"height":1429},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ovid-therapeutics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/vt\/"},{"@type":"ListItem","position":2,"name":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Ovid Therapeutics Inc. (OVID) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Ovid Therapeutics Inc. (OVID)"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/vt\/#website","url":"https:\/\/pocketoption.com\/blog\/vt\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"vt-VT"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/vt\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"vt_VT","wpml_translations":{"pt_AA":{"locale":"pt_AA","id":347686,"slug":"how-to-buy-ovid-therapeutics","post_title":"Como comprar a\u00e7\u00f5es da Ovid Therapeutics Inc. (OVID) - Investimento em a\u00e7\u00f5es da Ovid Therapeutics Inc. (OVID)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-ovid-therapeutics\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/347685","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/comments?post=347685"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/347685\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media\/334117"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media?parent=347685"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/categories?post=347685"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/tags?post=347685"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}